Neurizon Therapeutics Limited has released a press release.
Neurizon Announces Partial Redemption of Convertible Notes
Earlier from Neurizon Therapeutics
- NIH funds Expanded Access Program for NUZ-001 in ALS
- Neurizon Appoints Chief Executive Officer
- Appendix 4E and 2026 Annual Report
- Neurizon Enters Strategic R&D Financing Facility